• CME Group Market Data Policy UpdateCME Group Market Data Policy Update

      • To
      • CME Globex Customers
      • From
      • CME Global Account Management
      • #
      • 20100216
      • Notice Date
      • 16 February 2010
    • CME Group Market Data Policy Update

      CME Group requires that all use of market data be licensed and reported. This includes, but is not limited to, trading applications, analytic tools and automated systems. A brief overview of CME Group Market Data licensing and reporting policy obligations can be found at  www.cmegroup.com/marketdatapolicy.

      As part of our previously announced program to more diligently enforce required licensing and reporting obligations and to ensure continued compliance with all policies, CME Group is introducing a new streamlined and easy to implement Market Data License Agreement (MDLA) which:

      • Harmonizes legacy agreements and incorporates all policies and requirements for market data use and distribution
      • Ensures consistent application and enforcement for all customers
      • Protects CME Group's Intellectual Property

      Any entity connecting to CME Group for market data and/or distributing market data is required to sign the MDLA and comply with all reporting requirements by September 1, 2010. The MDLA is available now at  www.cmegroup.com/mdla.

      Those entities not in compliance by this date will forfeit any fee waiver for which they are eligible and will be subject to all applicable license fees.

      For questions related to the CME Group market data policy, the MDLA and access to the CME Group On-line Web reporting System (COWS), please contact  Information Products Management at 312.634.8395 or  Global Account Management at 312.634.8700 in the United States; 44.20.7796.7100 in Europe; and 852.3101.7696 in Asia.